2221. Comparison of Vancomycin with Either Piperacillin/Tazobactam or Cefepime for the Incidence of Acute Kidney Injury in a Patient Population with a High Prevalence of Preexisting Kidney Dysfunction

BACKGROUND: Frequently used agents for empiric antibiotic therapy include vancomycin, cefepime, and piperacillin/tazobactam (PTZ). Documentation exists to suggest the combination of vancomycin and PTZ increases the risk of acute kidney injury (AKI) more than either alone. This interaction has not be...

Descripción completa

Detalles Bibliográficos
Autores principales: Moran, Ryan, Harris, Jacklyn, Kolkmeyer, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677663/
http://dx.doi.org/10.1093/ofid/ofad500.1843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677663/
http://dx.doi.org/10.1093/ofid/ofad500.1843

Ejemplares similares